Invasion and metastasis markers in cancers

被引:25
作者
Chin, D [1 ]
Boyle, GM
Kane, AJ
Theile, DR
Hayward, NK
Parson, PG
Coman, WB
机构
[1] Queensland Inst Med Res, Melanoma Genom Grp & Human Genet, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Princess Alexandra Hosp, Head & Neck Unit, Brisbane, Qld, Australia
[3] Princess Alexandra Hosp, Dept Plast & Reconstruct Surg, Brisbane, Qld, Australia
来源
BRITISH JOURNAL OF PLASTIC SURGERY | 2005年 / 58卷 / 04期
关键词
proteases; adhesion proteins; prognostic markers;
D O I
10.1016/j.bjps.2004.12.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
Over 90% of all adults human cancers are of epithelia[ origin comprising mainly of skin and aero-digestive tract cancers. A significant proportion of our discipline's workload consists of management of these cancers. This review article is to provide clinicians with a summary of the current research findings in invasion and metastasis of epithelial cancers and the translation of some of this information to clinical use particularly related to skin and head and neck cancers (HNSCC). Metastasis is the leading cause of death in cancer patients. Although surgical resection of isolated metastases is beneficial for some patients, the overall efficacy of surgery, chemotherapy or radiotherapy is limited. Clearly, with today's advances in surgery a majority of these primary cancers are resectable and a cure attainable if surgeons could control or inhibit metastasis. (c) 2005 The British Association of Plastic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:466 / 474
页数:9
相关论文
共 84 条
[1]  
Abendstein B, 2000, ANTICANCER RES, V20, P569
[2]   VASCULAR ANATOMY AND ORGAN-SPECIFIC TUMOR-GROWTH AS CRITICAL FACTORS IN THE DEVELOPMENT OF METASTASES AND THEIR DISTRIBUTION AMONG ORGANS [J].
ARGUELLO, F ;
BAGGS, RB ;
ESKENAZI, AE ;
DUERST, RE ;
FRANTZ, CN .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (04) :583-590
[3]  
AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO
[4]  
2-L
[5]   Roles of the matrix metalloproteinases in mammary gland development and cancer [J].
Benaud, C ;
Dickson, RB ;
Thompson, EW .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (02) :97-116
[6]   Integrin expression and survival in human breast cancer [J].
Berry, MG ;
Gui, GPH ;
Wells, CA ;
Carpenter, R .
EJSO, 2004, 30 (05) :484-489
[7]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[8]   Matrix metalloproteinase inhibition: A review of anti-tumour activity [J].
Brown, PD ;
Giavazzi, R .
ANNALS OF ONCOLOGY, 1995, 6 (10) :967-974
[9]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[10]   Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma [J].
Charous, SJ ;
Stricklin, GP ;
Nanney, LB ;
Netterville, JL ;
Burkey, BB .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1997, 106 (04) :271-278